RonanRx: Vertically Integrated Pharmaceuticals for Peptides

The pharmaceutical industry suffers from a systemic architectural fragmentation. Modern medicine relies on a linear chain consisting of Electronic Health Record (EHR) systems, disparate telehealth portals, 3PL providers, and compounding pharmacies, where each node operates on siloed data protocols causing latency and price inflation.

RonanRx attempts to solve this via full-stack vertical integration. From a systems engineering perspective, this requires reconciling highly regulated physical manufacturing with high-velocity software infrastructure, eliminating manual intermediaries and antiquated EDI standards.

Stock photo for illustration only, not from the actual event

In traditional metabolic medicine, the feedback loop between patient physiological data and pharmaceutical dosage adjustment is broken. Standard mass-produced GLP-1 injectors are manufactured in rigid increments such as 2.5mg, 5.0mg, or 7.5mg, failing to account for biological reality where patient requirements are continuous variables.

The core engineering challenge lies in creating a digital-to-physical pipeline that allows for individualized formulation. The system must normalize disparate data sources including Continuous Glucose Monitoring (CGM) data and heart rate variability (HRV) history.

"Determine if the current dose is maintaining homeostatic stability or if the rate of weight loss is indicative of muscle mass attrition."

PatientTelemetryModel

In the Manufacturing Orchestration Layer, compounding processes are enhanced by integrating Laboratory Information Management Systems (LIMS) natively with prescribing engines, enabling precision dispensing hardware to move from fixed-dose vials to patient-calibrated syringes.

Source: Dev.to